相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The worldwide economic impact of dementia 2010
Anders Wimo et al.
ALZHEIMERS & DEMENTIA (2013)
The global prevalence of dementia: A systematic review and metaanalysis
Martin Prince et al.
ALZHEIMERS & DEMENTIA (2013)
Immunogenicity, Efficacy, Safety, and Mechanism of Action of Epitope Vaccine (Lu AF20513) for Alzheimer's Disease: Prelude to a Clinical Trial
Hayk Davtyan et al.
JOURNAL OF NEUROSCIENCE (2013)
Anti-Tau Antibodies that Block Tau Aggregate Seeding In Vitro Markedly Decrease Pathology and Improve Cognition In Vivo
Kiran Yanamandra et al.
NEURON (2013)
Efficacy and Safety of A Liposome-Based Vaccine against Protein Tau, Assessed in Tau.P301L Mice That Model Tauopathy
Clara Theunis et al.
PLOS ONE (2013)
Development of a New DNA Vaccine for Alzheimer Disease Targeting a Wide Range of Aβ Species and Amyloidogenic Peptides
Yoh Matsumoto et al.
PLOS ONE (2013)
Passive anti-amyloid immunotherapy in Alzheimer's disease: What are the most promising targets?
Jens Moreth et al.
IMMUNITY & AGEING (2013)
Mechanisms of Protein Seeding in Neurodegenerative Diseases
Lary C. Walker et al.
JAMA NEUROLOGY (2013)
Safety, tolerability, and antibody response of active Aβ immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study
Bengt Winblad et al.
LANCET NEUROLOGY (2012)
Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer's Association Research Roundtable Workgroup
Reisa A. Sperling et al.
ALZHEIMERS & DEMENTIA (2011)
DNA Immunization Against Amyloid beta 42 has High Potential as Safe Therapy for Alzheimer's Disease as it Diminishes Antigen-Specific Th1 and Th17 Cell Proliferation
Doris Lambracht-Washington et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2011)
The Second-Generation Active Aβ Immunotherapy CAD106 Reduces Amyloid Accumulation in APP Transgenic Mice While Minimizing Potential Side Effects
Christoph Wiessner et al.
JOURNAL OF NEUROSCIENCE (2011)
Resolving controversies on the path to Alzheimer's therapeutics
Dennis J. Selkoe
NATURE MEDICINE (2011)
Disease-modifying treatments for Alzheimer’s disease
Daniela Galimberti et al.
Therapeutic Advances in Neurological Disorders (2011)
Targeting Aβ and tau in Alzheimer's disease, an early interim report
Todd E. Golde et al.
EXPERIMENTAL NEUROLOGY (2010)
Efficacy and safety of immunization with phosphorylated tau against neurofibrillary tangles in mice
Moran Boimel et al.
EXPERIMENTAL NEUROLOGY (2010)
DNA prime-protein boost increased the titer, avidity and persistence of anti-Aβ antibodies in wild-type mice
H. Davtyan et al.
GENE THERAPY (2010)
Immunotherapy Targeting Pathological Tau Prevents Cognitive Decline in a New Tangle Mouse Model
Allal Boutajangout et al.
JOURNAL OF NEUROSCIENCE (2010)
Commentary on A roadmap for the prevention of dementia II. Leon Thal Symposium 2008. The Multidomain Alzheimer Preventive Trial (MAPT): A new approach to the prevention of Alzheimer's disease
Sophie Gillette-Guyonnet et al.
ALZHEIMERS & DEMENTIA (2009)
DEVELOPMENT OF AFFITOPE VACCINES FOR ALZHEIMER'S DISEASE (AD) - FROM CONCEPT TO CLINICAL TESTING
A. Schneeberger et al.
JOURNAL OF NUTRITION HEALTH & AGING (2009)
Aβ42 gene vaccine prevents Aβ42 deposition in brain of double transgenic mice
Bao-Xi Qu et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2007)
Immunotherapy targeting pathological tau conformers in a tangle mouse model reduces brain pathology with associated functional improvements
Ayodeji A. Asuni et al.
JOURNAL OF NEUROSCIENCE (2007)
Liposomal vaccines with conformation-specific amyloid peptide antigens define immune response and efficacy in APP transgenic mice
Andreas Muhs et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Site-specific UBITh® amyloid-β vaccine for immunotherapy of Alzheimer's disease
Chang Yi Wang et al.
VACCINE (2007)
Tau suppression in a neurodegenerative mouse model improves memory function
K SantaCruz et al.
SCIENCE (2005)
Clinical effects of Aβ immunization (AN1792) in patients with AD in an interrupted trial
S Gilman et al.
NEUROLOGY (2005)
Subacute meningoencephalitis in a subset of patients with AD after Aβ42 immunization
JM Orgogozo et al.
NEUROLOGY (2003)
Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide:: a case report
JAR Nicoll et al.
NATURE MEDICINE (2003)
Adjuvant-dependent modulation of Th1 and Th2 responses to immunization with β-amyloid
DH Cribbs et al.
INTERNATIONAL IMMUNOLOGY (2003)
Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease
F Bard et al.
NATURE MEDICINE (2000)
分享论文
